Trial

Evaluating Celecoxib Activity in Mycobacterium tuberculosis: a Whole Blood Bactericidal Activity Study in Healthy Volunteers

Study Director
Nicholas Paton
Start Date
11 / 2015
Trial Phase
Phase I
Trial Status
in data analysis
Current Enrollment
Target Enrollment
18
Overview
Recruiting Evaluating Celecoxib Activity in Mycobacterium Tuberculosis: A Whole Blood Bactericidal Activity Study in Healthy Volunteers
Condition: Tuberculosis
Interventions: Drug: Celecoxib;   Drug: Rifampicin;   Drug: Pyrazinamide
Study Type: Interventional
Phase: Phase 1
Sponsor: National University Hospital, Singapore
Number Enrolled: 18
NCT Number: NCT02602509
Other IDs: Celecoxib_WBA
Study Start: November 2015
Primary Completion: April 2016
Study Completion: April 2016
Last Updated: November 9, 2015
Data obtained from Clinicaltrials.gov 10 March 2017
Registry Link
Compound Associations
Celecoxib